4. Neoplasia Stom Eng 2011

download 4. Neoplasia Stom Eng 2011

of 58

Transcript of 4. Neoplasia Stom Eng 2011

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    1/58

    Pathophysiology department, faculty of

    Stomatology, 29.09.2011

    Pathophysiological pathways of Tumor Growth

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    2/58

    Design of lecture

    1. Typical forms of cell growth disturbance

    2. Definition of Tumor Growth

    3. Etiology

    4. Risk factors5. Pathogenesis of Tumor growth

    6. Major features of cellular growth regulation

    7. Molecular mechanisms of cancer8. Neoplastic atipisms (Anaplasia)

    9. Antineoplastic resistance

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    3/58

    Glossary

    1. Neoplasianew growth

    2. Tumor are named according to the tissue of origin with the

    suffix oma added

    3. Cancer refers to a malignant tumor

    4. Tumor cell markersare substances that are produced by cancer

    cell and found on tumor plasma membranes or in the bloodspinal fluid, urine (they include hormones, enzymes, genes,

    antigens, antibodies)

    5. Oncogenes are genes that can transform a normal cell into acancerous

    6. Proto-oncogenes are normal genes, that regulate growth and

    development by encoding for growth factors (GF) and GF

    receptors

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    4/58

    Glossary

    7. Heterozygosityloss of one gene copy

    8. Transformationthe process by which a normal cell becomes

    a cancer cell

    9. Anchorage independentthey can continue to divide in a softagar gel

    10. Autonomyrefers to the cancer cells indepence from normalcellular controls

    11. Autocrine stimulatingthe ability to secrete GF that stimulatetheir own growth

    12. Epigeneticsthat dont involve changes in DNA sequence

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    5/58

    NeoplasiaDefinition

    1. A tumor is an abnormal mass of tissue, thegrowth of which is virtually autonomous and

    exceeds that of normal tissues (by Robbins)

    2. A tumor is abnormal mass of tissue, the growthof which exceeds and is uncoordinated with that of

    the normal tissue and persists in the same excessive

    manner after the cessation of the stimuli, which

    avoke the change (by Willis)

    3.Cancer is a disease of abnormal cell growth,

    division and cell proliferation (by McCance,

    S. Huether)

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    6/58

    Memory check !

    Cell cycle

    1) The reproduction or division of somatic

    cells involves two sequential phases: mitosis (nuclear division) and interphase

    cytokinesis (cytoplasmic division)

    Beginning toward the end of mitosis

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    7/58

    Memory check !

    2) Before a cell can divide, it must double its massand duplicate all of its contents. Most of thepreparation for division occurs during the

    growth phase (interphase)

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    8/58

    Memory check !

    3) There are four designated phases of the cell cycle:I. The S phase (synthesis)in which DNA is synthesized

    in the cell nucleus

    II. The G2 phase, in which RNA and protein synthesis

    occurIII.The M phase (mitosis) which includes both nuclear

    and cytoplasmic division

    IV. G1 I phase, which is the period between the M phase

    and the start of DNA synthesis Interphase, which consists of the G1, S and G2

    phases, is the longest phase of the cell cycle.

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    9/58

    Memory check !

    4) Gene and protein growth factors govern the proliferation

    of different cell types Cells require highly specific proteins to stimulate cell

    division. These growth factors are present in the serum invery low concentration (for example platelet-derivedgrowth factor stimulates the production of connective

    tissue cells, or interleukin which stimulates theproliferation of T-cells)

    Cells have specific receptors for the specific growth factorin their plasma membrane. Some growth factors are also

    regulators of cell differentiation. It is likely that some genes code for growth factors, some

    for receptors, some for intracellular regulatory proteins,some for proteins that help relay signals for cell divisionto the cell nucleus

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    10/58

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    11/58

    Epidemiology

    General facts Cancer is the second leading cause of

    death in the United States and other

    countries Estimated number of new cancers in

    2005 (1.372.910)

    Estimated number of deaths from cancerin 2005 (570.280)

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    12/58

    EtiologyCarcinogenic Agents

    1. Chemical carcinogenes

    2. Radiation (physical)

    3. Oncogenic viruses, bacterial cause

    4. Role of inflammation, immunity in cancer

    5. Loss of immune regulation and chronicinflammationn (parainflammation)

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    13/58

    1. Clinically important chemical carcinogenic

    a. Polycyclic Aromatic hydrocarbons: present in cigarette smokeb. Azo dyes: -naphtylamine, aniline

    c. Nitrosamines and amides (synthesized from nitrites in GIT)

    d. Naturally occurring carcinogens (aflatoxin produced by the fungus

    aspergillus flavus on moldy grains, peantus)

    e. Alkalating agents

    f. Miscellaneous agents: Asbestos, vinyl chloride, metals (nickel),

    arsenic, benzene, beryllium, cadmium, chromium component,

    ethylene oxide

    g. Hormones (estrogen)

    h. Free radicals

    Chemical agents

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    14/58

    Chemical carcinogenesis

    Carcinogenesis is multistep process involving asequence of initiation (mutation) followed by

    promotion (proliferation) and progression

    Initiators: direct acting, non-direct acting

    chemicals

    Promotors - cause cellular proliferation of mutated

    (initiated) cells. Proliferation may lead to

    accumulation of additional mutations

    Tumor progression appearance of subpopulation

    which differ with respect to several phenotypic

    attributes

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    15/58

    Human viruses associated with cancer

    Virus family Types

    1. Hepatitis viruses Hepatitis B

    2. Herpesviruses Epstein-BarrKSHV/HHV-8 is linked toimmunodeficiency

    3. Papillomaviruses HPH-16, HPV-18,31-other

    4. Retroviruses HTLV-1

    Hepatitis C

    d

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    16/58

    Viral and microbial carcinogenesisDNA-viruses

    HPV (human papilloma virus)

    Epstein-Barr viruses (EBV) Hepatitis B virus(HBV) HPV cause benignsquamous (warts)in human, supporting

    role in human cancers (cervical cancers) anogenital

    Epstein-Barr viruses(EBV-member of the herpes virusfamily) is associated with four human cancers:a. Burkitt lymphoma,b. Nasopharingeal cancer,

    c. B-cell lymphoma in immunosuppressive patients (AIDS),d. Some forms of Hodgkin disease.Kaposi sarcoma- associated withherpesvirus (HHV8)Hepatitis B virus (HBV)-hepatic cancer, hepatocellular

    carcinoma

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    17/58

    C virusRNA viruses

    human oncegenic retrovirus is

    Human T-cell lymphotropic virus type 1

    (HTLV-1)

    Linked to the T-cell Leukemia/lymphoma

    Hepatitis C virus

    Bacterial cause cancer (microbial factors)

    It is also associated with gastric lymphomas

    Mechanism: H. pylori infection induces methylation of

    specific genes in the gastric mucosa.

    HP helicobacter pylori induced

    Gastric ulcer and carcinoma

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    18/58

    Radiation(Carcinogenesis)

    Ultraviolet Rays (sunlight) Ionizing

    radiation X- rays, - rays, -, - particles,

    protons, neutronsEffects: transcriptional errors and mutations

    Physical factors

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    19/58

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    20/58

    Risk factors

    Gender: In man cancer of lung, colon and prostate are theleading causes of cancer death; in woman- breast, colon,

    lung are most common forms Geographic and Environmental factors:Japan-the death

    rate from cancer of the stomach 7 times that in England,USA

    Cancer of the breast in England, USA rate increases, but inJapan decreases Carcinoma of colon is much less common as a cause of

    death in Japan

    Increased risk of certain cancers with exposure to asbestos,alcohol vinyl chloride, 2-naphtylamine Association of carcinoma of the or pharynx, larynx, and

    lung with cigarette smoking

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    21/58

    Risk factors

    Age:Cancer is most common in those older than 55

    years of age, certain cancers are particularity commonyounger than 15 years of age:

    Leukemia and lymphomas Tumor of the hematopoietic system

    Neuroblastoma

    Wilms tumor Retinoblastomas

    Sarcomas of bone and skeletal muscle

    Ri k f

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    22/58

    Risk factorsI. Heredity:

    1. Inherited cancer syndrome (inheritance by single mutant genes,autosomal-dominant trait):

    a. familial retinoblastoma,

    b. familial adenomatous polyposis

    c. multiple endocrine neoplasia

    2. Autosomal recessive syndromes of defective DNA repairChromosome DNA instability Increased by environmental carcinogens.

    II. Acquired preneoplastic disorder; (clinical conditions which areassociated with an increased risk of developing cancers)

    Cirrosis of liver-hepatocellular carcinoma

    Atrophic gastritis or pernicious anemia - stomach cancer

    Chronic ulcerative colitis - carcinoma of the colon

    Leukoplakia of the oral and genital mucouse - squamous cell cancers

    Certain benign tumor (e.q. village adenomas of the colon )

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    23/58

    NOTE!

    (inflammation, immunity, and cancer)

    1. Chronic inflammation (and more specifically

    parainflammation) has been recognized as being an

    important factor in the developments of cancer (ex.

    sialedenits salivary gland carcinoma)

    2. Although the immune system is indeed important in

    protecting us against cancers caused by specific viral

    infections, it does not effectively protect us against

    most common cancers (breast or prostate lung, colon

    cancer).

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    24/58

    Characteristics of neoplasma:

    Differentiation (loss) and anaplasia

    Pleomorphism (variation size)

    Hyperchromasia

    High N/C (nucleous/cytoplasma) ratio (normal 1:4-1:6)

    Disturbed orientation

    Displasialoss in uniformity of individual cells and less intheir architectural orientation

    Anaplasia (hallmarks of cancer cell)

    The loss of cell differentiation, irregularities of the size and

    shape of the nucleus, and loss of normal tissue structure.

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    25/58

    Classification

    Due to on the characteristic of their

    parenchyma

    Benign Malignant

    Based on 4 criteria

    1. Differentiation and anaplasia

    2. Rate of growth3. Local invasion

    4. Metastases

    C i

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    26/58

    Rate of growth and local invasion

    Benign: slow growing, cohesive, expansive

    capsuleMalignant: Autonomy,Infiltration, Invasion,

    destruction, and metastasis

    Most reliable feature of malignancyis theMetastasis

    2nd most reliable featureInvasiveness

    Comparison

    C ll d fi d b h i bl

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    27/58

    Cancer cells are defined by two heritable

    properties: 1. autonomy and 2. anaplasia

    (literally without form)

    1. Cancer cells

    independence fromnormal cellularcontrol

    2. Is a loss of

    differentiation

    Cancer cells has lost its ability

    1) to function normally

    2) to control its growth and division

    PATHOGENESIS OF NEOPLASIA

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    28/58

    The target molecules are:

    Protooncogenes Oncogenes

    Tumor suppressor genes

    Telomeres/reactivation of telomeraseApoptosis prevention gene

    Caretaker genes (DNA repair)

    The Molecular Basis of Cancer is a

    non lethal genetic damage!

    PATHOGENESIS OF NEOPLASIA

    Carcinogenesis

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    29/58

    Carcinogenesis

    Carcinogenesis multistep process:

    Four classes of genes are the targets of geneticdamage:I. Growth-promoting proto-oncogenes (oncogenes)

    II. Growth-inhibiting tumor-supressor genes

    III. Genes that regulate apoptosis

    IV. Genes that regulate DNA repair

    General : Activation of growth promoting

    Inactivation of Tumor suppressor genes

    Disregulation , Resistance to apoptosis

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    30/58

    Pathogenesis of Tumor

    1. Carcinogenesis is a multistep process

    2. Development of C. requires the accumulationof multiple genetic changes:Inherited germ line mutation

    Acquired mutation1. Tumor is derived from monoclonal expansionof mutated cell

    2. Host important mutations in:a. Growth promoting genes (protooncogenes)

    b. Growth inhibiting tumor suppressor genes

    c. The genes regulating apoptosis

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    31/58

    Cell cycle regulation

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    32/58

    The sequence of events that characterize

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    33/58

    The sequence of events that characterizenormal cell proliferation

    Under physiologic conditions all proliferation can be readily

    resolved into the following steps: The binding of a growth factor to its specific receptor on the

    cell membrane

    Transient and limited activation of the growth factor receptor,

    which in turn activates several signal transduction proteins on the

    inner half of the plasma membrane

    Transmission of the transduced signal across the cytosol to the

    nucleous via second messengers

    Induction and activation of nuclear regulatory factors that

    initiate DNA transcription

    Entry and progression of the cell into the cell cycle resulting

    ultimately in cell division

    Gentetic disturbances of any of the above leads to transformation.

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    34/58

    Transformation due to genetic disturbance of:

    Growth factors Growth factors receptors

    Signal transducting

    Regulation transcription

    Normal Cell

    Tumor Cell

    Transformed proliferation

    Abnormal and autonomy

    regulation

    of growth

    Disturbance of replication

    Pathogenesis of cancer

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    35/58

    Pathogenesis of cancer

    Normal cell

    DNA damage

    Mutations in the genome of somatic cells

    Genetic factors inherited

    mutations in genes affecting

    Cell growth or DNA repair

    Acquired

    environmental

    factors: chemical,radiation, viruses

    Activation of growthpromoting oncogens

    Inactivation of cancersuppressor genes

    Alteration of genesthat regulate apoptosis

    Expression of altered

    gene product and lossof regulatory gene products

    Oncoproteins

    Malignant Neoplasm

    Clonal expansion

    Additional mutation

    (progression)

    Heterogenity

    Pathogenesis of Tumor

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    36/58

    Pathogenesis of TumorI. Activation of protooncogen oncogens

    Protooncogenes are normal cellular genes involved with growth and

    cellular differentiation1. Oncogenes are derived from protooncogenes by either

    a. A change in the gene sequence, resulting in a new gene product(oncoproteins)

    b. Loss of gene regulation resulting in overexpression of the normalgene product

    2. Mechanisms of oncogene activation

    a. Point mutation

    b. Chromosomal translocationc. Gene amplification(reduplication of oncoproteins)

    d. Insertions, deletions

    e. Gene silencing (DNA methilation, histone modification)

    f. Exogenous sequences (tumor) viruses

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    37/58

    Turning off genes without mutation (epigeneticsilencing is caused by reversible chemical

    modification methylation, acetylation of histones,DNA methylation ets.)

    Epigenetic mechanisms in the pathogenesis oftumor growth: gene silencing

    Protein prod cts of oncogenes

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    38/58

    Protein products of oncogenes

    1. Growth factors

    2. Growth factors receptors3. Signal transducting proteins (guanosine GTP-

    triphosphate binding proteins and non-receptorassociated tyrozine kinase)

    4. Nuclear transcription proteins (mus,jun,fos)

    5. Cyclins and cyclin - dependent kinases regulatethe progression of cells through the cell cycle

    Note! Activated oncogenes lack regulatory control and

    are over expressed, resulting in unregulated cellular

    proliferation

    Pathogenesis of Tumor

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    39/58

    II. Inactivation of tumor suppressor genes (TSG)

    Pathogenesis of Tumor

    Rb Retinoblastoma

    WT-1, - 2 Wilms TUMOR

    p53 Lung, breast, colon etc.

    APC Adenomatous polyps andcolom cancer

    BRCA -1 breast cancer

    NF-1, -2 neurofibromas, neuromas

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    40/58

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    41/58

    TSG encode proteins that regulate andsuppress cell proliferation by inhibiting

    progression of the cell through the cell cycle.

    Mechanisms of action of some tumor

    suppressor genes.

    a. P53 prevents a cell with damaged DNA from

    entering S-phase

    b. Rb prevents the cell from S-phase until theappropriate growth signals are present

    Pathogenesis of Tumor

    III Impairment of the regulation of Apoptosis

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    42/58

    III. Impairment of the regulation of Apoptosis

    1. Over expression of Bcl-2 - prevent apoptosis (in

    follicular lymphomas)2. Low expression, blocked genes promoting

    apoptosis bax, bad, bcl-xs, bid

    3. Mutation of p53 promotes apoptosis in mutatedcell by stimulation bax synthesis

    4. c-myc promotes cellular proliferation

    when associated with p53 leads to apoptosis

    when associated with Bcl-2 inhibits apoptosis

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    43/58

    Role of telomerase

    21

    TumorSenescentpostmitotic

    cell

    IV Telomeres/telomerases

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    44/58

    IV. Telomeres/telomerases

    ATTENTION! Other than germ cells, body cellscouldnt unlimited divided, because of regulation by

    telomeres. There are control the activity of chromosome.Telomeres are protective ends or caps and becomesmaller with each cell division. Short telomeres normallysignal the cell to cease cell division. Cancer cells, when

    they reach a critical age, activate telomerase, whichrestore and maintain telomeres resulting in to divideover and over again immortality of cancer cell.

    Shortening of telomere take place after each division

    of cell. In tumor cells due to specific enzymestelomerases telomeres are permanently recovered. So,there is unlimited division of cell.

    V. Disorder of DNA repair Caretaker genes mutations

    Growth of the tumor and its transformation

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    45/58

    Growth of the tumor and its transformation

    Progression of the tumor

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    46/58

    20

    Progression of the tumor

    Main hallmarks of cancer

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    47/58

    Increase selfproductionin growth signalsautocrine regulation

    Inactivation of antigrowthsignals

    Resistance (evading) toapoptosis

    Limitless replicativepotential

    Sustained angiogenesis Tissue invasion and

    metastatis + Warburg effects ?

    Main hallmarks of cancer

    Metastatic avenues/sequence

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    48/58

    Metastatic avenues/sequence

    Neoplastic cell multiplication and local invasion

    Lymphatic Blood vessels

    Penetration

    Cellulardeath

    Cellulargrowth

    Efferentlymphaticentrance

    Noneoplasm

    Extravasations

    Organ tropism

    New growth site

    AngiogenesisMetastatic neoplasm

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    49/58

    Angiogenesis

    Cancer needs blood/supply to deliver O2 and

    nutrients. Cancer has ability to grow new blood

    vessels. Cancer can secrete factors that stimulate

    new blood vessel growth angiogenesis.

    Example of angiogenic factor is vascular

    endothelial growth factor (VEGF) (other factors).

    Biological properties of benign and malignant tumors

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    50/58

    Biological properties of benign and malignant tumors

    (Activisms)1. Abnormality of proliferation

    a) unregularity of proliferation,b) Loss of proliferation limit,

    2. Abnormality of differentiation

    3. Abnormality of metabolism and energy production

    a) Tendency to anaerobic glycolysis (Warburg effect)Increased production of oncoproteins,

    b) Synthesis of embryonic proteins,

    c) Change of resynthesis of energy,

    d) Phenomenon of metabolic traps (glucose, aminoacids),

    e) Decrease concentration of c-AMP and increase concentration of c-GMP,

    4. Physico-chemical abnormality (K+, Ca2+)

    5. Antigenic abnormality (iso, transplatatory, embryonic,

    hetero)

    Biological properties of benign and malignant tumors

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    51/58

    Biological properties of benign and malignant tumors

    (Atipisms)

    6. Morphologic abnormality

    7. Abnormal functioning

    a) Inhibition of functions,

    b) Increase of functions,

    c) Disturbance of functions

    8. Abnormal tumor cell-to-host organism interaction

    a) immunodepression,

    b) Ectopic endocrine syndromes

    c) Influence of stress,d) Cardiovascular insufficiency

    e) Muscular dystrophy,

    f) Amino acid, energetic, antioxidative, vitamine and

    other deficits

    Antineoplastic resistance of organism

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    52/58

    Antineoplastic resistance of organism

    1. Anticarcinogenic (inactivation, elimination, pinocytosis,

    interferon, antibodies, antioxidants)

    2. Antitransformational (DNA repair enzymes, antioncogenic

    mechanisms)

    3. Anticelular (specific and non specific, immune protection,

    TNF, IL-1, allogen inhibition by the normal cells, keilons:tissue

    specific mitogen supressors 1lipoprotein cancerolysis,contact inhibiting, cAMP+, cGMP-, labrocytosis, increase ofhumoral protection)

    Pathways of increase antineoplastic resistance

    Activation of apoptosis

    Immunotherapy

    Photodynamic therapy

    Biotechnology

    Typical Test

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    53/58

    Typical Test1. Choose the correct definitions:

    a) A tumor is an abnormal mass of tissue, the growth ofwhich is virtually autonomous and exceeds that of thenormal tissues

    b) Cancer is a disease of abnormal cell growth, division andcell proliferation

    c) Tumor is a increase of a number of cell

    d) Tumor is a hyperplasia and hypertrophia of tissueI. a,c II. b,d, III. a,b IV. a,b,c,d

    2. All the following are causes of tumor, EXCEPT:

    a) Epstein-Barr virusesb) HTLV-1c) Megalovirused) Hepatitis B-Ve) Human herpes viruses

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    54/58

    3. All the following are the chemical causes of cancer, EXCEPT:

    a)Asbestos

    b)Vinyl chloride

    c) PgE1

    d)Arsenic

    e) Benzene

    4. All the followingare the cancer-induced DNA-viruses, EXCEPT:

    a) HPV

    b) EBV

    c) HBVd) HTLV-1

    e) HHV8

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    55/58

    5. Which are the endogenous carcinogenic chemicals:

    a) Free radicals

    b) Aflatoxinc) Vinyl chloride

    d) Estrogen

    I. a,b II. b,c III. c,d IV. a,d

    6. Warburg effect is manifested by:

    a) Activation of growth promoting protooncogenes

    b) Activation of antioxidantsc) Increased oxygen consumption

    d) Activation of anaerobic glycolusis

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    56/58

    7. Which of the following suppressor gene is related with apoptosis:

    a) Rb

    b) p53

    c) APCd) NF-1

    I. a,b II. b,c III. c,d IV. a,d

    8. Choose the four classes of genes, which are the targets of tumor growth

    a) Genes that regulate DNA repair

    b) Genes that regulate adhesion molecules synthesis

    c) Genes that regulate apoptosis

    d) Inhibiting genese) Protooncogens

    I. a,b,c,d,e II. a,b,c III a,c,d,e IV. c,d,e

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    57/58

    9. Which of the following about mechanisms of oncogene activation is false:

    a) Point mutation

    b) Chromosomal translocation

    c) Amplification

    d) Insertion of mutagens

    e) DNA repair

    10. False statement about tumor suppressor gene is:

    a) TSG encode proteins that regulate and suppress cellproliferation

    b) p53 prevents a cell with damaged DNA from entering S-phasec) Rb prevents the cell from S-phase until the growth signals are

    present

    d) TSG encode proteins of growth receptors

  • 8/3/2019 4. Neoplasia Stom Eng 2011

    58/58

    11.Biological properties of tumors are following

    a) Immunodepression

    b) Antioxidants deficitc) Increase concentration of cAMP

    d) Decrease concentration of cGAM

    e) Phenomenon of metabolic traps.

    I. a,b,c II. d,e III. a,b,c,e

    12. All the following are antineoplastic resistance , EXCEPT:

    a) Antioxidants

    b) Decrease of cAMPc) Allogen inhibition

    d) Labrocytosis